Bioscreen Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 17-01-2025
- Paid Up Capital ₹ 0.10 M
as on 17-01-2025
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.19 Cr
as on 17-01-2025
- Satisfied Charges ₹ 3.54 Cr
as on 17-01-2025
- Revenue 7.04%
(FY 2023)
- Profit -21.77%
(FY 2023)
- Ebitda -2.39%
(FY 2023)
- Net Worth 14.62%
(FY 2023)
- Total Assets 32.06%
(FY 2023)
About Bioscreen Instruments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹22.19 Cr. The company has closed loans amounting to ₹3.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
Radhakrishnan Sathyamoorthy and Sathiamoorthy Prabhakar serve as directors at the Company.
- CIN/LLPIN
U51507TN2005PTC055221
- Company No.
055221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bioscreen Instruments Private Limited offer?
Bioscreen Instruments Private Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Pathology Lab Equipments, Elisa Reader, Microplate Reader, Material Handling Equipments, Material Handling Systems, Machines & Equipments, Vacuum Based Machinery, Biometrics & Access Control Devices.
Who are the key members and board of directors at Bioscreen Instruments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sathiamoorthy Prabhakar  | Director | 10-Oct-2011 | Current |
| Radhakrishnan Sathyamoorthy | Director | 27-Jan-2005 | Current |
Financial Performance of Bioscreen Instruments.
Bioscreen Instruments Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.04% increase. The company also saw a substantial fall in profitability, with a 21.77% decrease in profit. The company's net worth Soared by an impressive increase of 14.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioscreen Instruments?
Unlock access to Bioscreen Instruments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Careworx Healthcare Private LimitedActive 2 years 11 monthsSathiamoorthy Prabhakar is a mutual person
Bioscreen Lab Instruments LlpActive 4 years 9 monthsRadhakrishnan Sathyamoorthy and Sathiamoorthy Prabhakar are mutual person
Drumbuffer Analytics Private LimitedActive 6 years 7 monthsSathiamoorthy Prabhakar is a mutual person
Charges (Loans)
₹221.88 M
₹35.38 M
Charges Breakdown by Lending Institutions
- Others : 21.05 Cr
- Hdfc Bank Limited : 1.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2024 | Others | ₹1.00 Cr | Open |
| 23 Apr 2024 | Hdfc Bank Limited | ₹9.28 M | Open |
| 30 Aug 2021 | Hdfc Bank Limited | ₹1.10 M | Open |
| 27 Jan 2021 | Hdfc Bank Limited | ₹1.01 M | Open |
| 16 Dec 2019 | Others | ₹20.05 Cr | Open |
How Many Employees Work at Bioscreen Instruments?
Bioscreen Instruments has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioscreen Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioscreen Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
